ENDO 2010 Annual Meeting - Includes 5 Complimentary Sessions
Click here to go to the previous page
CLINICAL - Dyslipidemia beyond the Statin
Program Code:
CMF02
Date:
Saturday, June 19, 2010
Time:
2:45 PM to 3:30 PM
EST
SPEAKER
(S):
Kenneth Feingold, MD, Univ of California-San Francisco/VAMC, San Francisco, CA
Disclosure: Speaker, Amylin Pharmaceuticals, Lilly USA, LLC, Abbott Laboratories, AstraZeneca, Merck & Co., Takeda, Bristol-Myers Squibb; Principal Investigator, Merck & Co.
Lisa R. Tannock,
MD,
Univ of Kentucky, Lexington, KY
Disclosure: Nothing to Disclose